Despite a series of positive industry catalysts, the landscape is looking a lot grimmer for many cannabis companies in 2019.
HEXO Corp HEXO HEXO stock fell over 22% Thursday after the company released preliminary fourth-quarter net revenue results. The preliminary figure of CA$14.5 million ($10.9 million) to CA$16.5 million ($12.4 million) missed guidance that called for CA$24.8 million.
The major sell-off was associated with company’s decision to withdraw its 2020 earnings guidance.
"HEXO imploded on a huge quarterly revenue miss and the retraction of guidance, and Village Farms priced an equity offering," cannabis market analyst Alan Brochstein told Benzinga.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
Five other cannabis companies experienced sell-offs Thursday as Hexo plummeted.
Tilray TLRY was down 13.49% at the close, although it was gaining some of that loss back in the after-hours session. Canopy Growth CGC saw a 10.56% loss in the regular session. The company announced Thursday that Constellation Brands, Inc. STZ CFO David Klein as its board chairman.
Cronos Group CRON shares were down 7.23%.
Aurora Cannabis ACB stock fell 9.49%, and Aphria APHA was second only to Hexo in its losses, falling 14.29%.
The Horizons Marijuana Life Sciences Index ETF HMLSF is showing a year-to-date drop of over 42%, while the ETFMG Alternative Harvest ETF MJ is down almost 50% year-to-date.
Sam Masucci, CEO of ETF Managers Group, which also runs the ETFMG Alternative Harvest ETF, said on CNN this week that "the sector is very volatile and that's to be expected given the nascence of the business. It's still a new market."
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF